Cannabis Clinical Trials

PHOENIX, April 26, 2018 (GLOBE NEWSWIRE) — NSYS Therapeutics, Inc. (NASDAQ:INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today announced a collaboration with the University of California (UC) San Diego School of Medicine’s Center for Medicinal Cannabis Research (CMCR) to study cannabidiol (CBD) as a potential treatment for […]

by

TEL AVIV, Israel, April 25, 2018 /PRNewswire/ — Israeli startup Kanabo Research, which develops clinical solutions for extraction and vaporization of medical cannabis, announces it is entering an agreement with Constance Therapeutics, a US-based medical cannabis extraction company. … read more at: https://www.prnewswire.com/news-releases/israel-based-medical-cannabis-solutions-provider-kanabo-research-has-signed-an-agreement-with-constance-therapeutics-from-the-us-300636240.html

by

House Judiciary Chairman Bob Goodlatte has agreed to co-sponsor a Florida Republican’s bipartisan bill to make medical marijuana research easier, his office confirmed on Wednesday. That backing by the conservative Virginia Republican potentially bolsters the bill’s chances in the House. Representative Matt Gaetz started circulating a handout Tuesday night explaining his Medical Cannabis Research Act, […]

by

LAS VEGAS, April 10, 2018 /PRNewswire/ – GB Sciences, Inc. (OTCQB: GBLX) is planning to file an Exploratory IND and perform a Phase 0 Clinical Trial to gather valuable First-In-Human data on its proprietary cannabis-based therapies for the treatment of early to moderate Parkinson’s disease (“PD”).  The GB Sciences’ Exploratory IND program is designed to allow […]

by

Even after months of wrangling, the Israeli government is “still working extensively” on a decision to approve the legalization of medical cannabis exports as part of a set of reforms already underway in the country since 2016, Israeli Minister of Agriculture Uri Ariel announced on Tuesday at the first state-backed medical cannabis conference near Tel […]

by

A brownie recipe for every workday, because you’ve earned it The world is full of delicious desserts. Brownies, though, are a classic. They’re inherently nostalgic, sweet but not necessarily a sugar bomb. … read more at: https://www.washingtonpost.com/graphics/2018/health/marijuana-science/

by

Image: StockSnap Australian company Zelda Therapeutics Ltd (ASX: ZLD) has announced it has completed patient recruitment for its insomnia trial. Zelda received approval to conduct a clinical trial of its cannabis medicines with chronic insomnia patients in Australia in December last year. With recruitment now completed, the next phase will see  patients undergoing baseline sleep […]

by

Hosted by the world’s first cannabis and hemp innovation accelerator, Greenhouse Ventures, the Cannabis Learn Conference and Expo in Philadelphia is an exclusive opportunity for those invested in the industry to learn about market trends from leading operators, political insiders, and university researchers in cannabis today. The brainchild of company co-founders Tyler Dautrich and Kevin […]

by

A federal advisory committee unanimously voted in favor of a marijuana-based medication that helps children with severe epilepsy. On Thursday, the 13-member panel, including UT Health San Antonio doctor Jose Cavazos, recommended the drug called Epidiolex. It’s created by British company GW Pharmaceuticals to help treat rare and severe forms of epilepsy. The drug contains […]

by

Zelda Therapeutics Ltd (ASX:ZLD) has completed patient recruitment for Australia’s first clinical study of medical cannabis to treat insomnia. The next phase of the study will commence shortly with patients undergoing baseline sleep measurements before commencing pharmaceutical dosing. Positive results will mean Zelda will rapidly focus on commercialisation Zelda’s executive chairman Harry Karelis said: “This […]

by